Layered learning pharmacy practice model in Ethiopia
- 7 January 2019
- journal article
- research article
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 25 (7), 1699-1704
- https://doi.org/10.1177/1078155218820105
Abstract
Ethiopia is home to a growing population of more than 100 million people. Healthcare in the region functions with a shortage of oncologists. Pharmacists as well as other healthcare providers can assist with expanding patient access to cancer care. A pilot project was proposed to provide education, determine areas to expand pharmacy services in oncology, and recommend interventions at Tikur Anbessa Specialized Hospital and Addis Ababa University. A layered learning practice model comprising of a clinical pharmacist, a post-graduate year two oncology pharmacy resident, and two fourth-year student pharmacists was constructed for the experience. Through collaboration with the College of Pharmacy at Addis Ababa University, an international experience was developed to provide education and advance pharmacy practice at Tikur Anbessa Specialized Hospital. Based on findings from a needs assessment, the participants collaborated with key stakeholders to develop practices and procedures for the implementation of high-dose methotrexate and for comprehensive chemotherapy order review. In addition, 17 didactic lectures were provided to nine students enrolled in the Master of Pharmacy in Pharmacy Practice at the College of Pharmacy at Addis Ababa University. This experience provided educational and clinical impact using a layered learning practice model, consisting of a clinical pharmacist, pharmacy resident, and pharmacy students in an international setting. There is significant potential for clinical pharmacy to positively impact patient care in the oncology setting in Ethiopia. Future initiatives for advancement include the safe handling of hazardous agents, additional therapeutic drug monitoring, and outpatient oncology pharmacist practice.Keywords
This publication has 13 references indexed in Scilit:
- Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group Study AALL0232Journal of Clinical Oncology, 2016
- A Study of Layered Learning in OncologyAmerican Journal of Pharmaceutical Education, 2016
- Attitude and satisfaction of health care providers towards clinical pharmacy services in Ethiopia: A post-deployment surveyJournal of Pharmaceutical Policy and Practice, 2016
- Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled TrialJournal of Clinical Oncology, 2015
- The State of Cancer Care in America, 2015: A Report by the American Society of Clinical OncologyJournal of Oncology Practice, 2015
- Advancing the pharmacy practice model in a community teaching hospital by expanding student rotationsAmerican Journal of Health-System Pharmacy, 2014
- Cancer in EthiopiaThe Lancet Oncology, 2013
- Role of Oncology Clinical Pharmacists in Light of the Oncology Workforce StudyJournal of Oncology Practice, 2010
- Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemiaCancer, 2006
- Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic LeukemiaJournal of Clinical Oncology, 2000